WO2007144080A3 - Antidepressiva-kombinations-wafer - Google Patents
Antidepressiva-kombinations-wafer Download PDFInfo
- Publication number
- WO2007144080A3 WO2007144080A3 PCT/EP2007/004936 EP2007004936W WO2007144080A3 WO 2007144080 A3 WO2007144080 A3 WO 2007144080A3 EP 2007004936 W EP2007004936 W EP 2007004936W WO 2007144080 A3 WO2007144080 A3 WO 2007144080A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- combination
- active ingredient
- depression
- antidepressants
- wafer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07725804A EP2029097A2 (de) | 2006-06-16 | 2007-06-04 | Antidepressiva-kombinations-wafer |
JP2009514661A JP2009539892A (ja) | 2006-06-16 | 2007-06-04 | 組み合わせ抗うつ薬ウェーハ |
CA002652476A CA2652476A1 (en) | 2006-06-16 | 2007-06-04 | Combination antidepressants wafer |
US12/308,194 US20090203670A1 (en) | 2006-06-16 | 2007-06-04 | Combination Antidepressants Wafer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006027792.9 | 2006-06-16 | ||
DE102006027792A DE102006027792A1 (de) | 2006-06-16 | 2006-06-16 | Antidepressiva-Kombinations-Wafer |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007144080A2 WO2007144080A2 (de) | 2007-12-21 |
WO2007144080A3 true WO2007144080A3 (de) | 2008-04-24 |
Family
ID=38667454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/004936 WO2007144080A2 (de) | 2006-06-16 | 2007-06-04 | Antidepressiva-kombinations-wafer |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090203670A1 (de) |
EP (1) | EP2029097A2 (de) |
JP (1) | JP2009539892A (de) |
CN (1) | CN101460145A (de) |
CA (1) | CA2652476A1 (de) |
DE (1) | DE102006027792A1 (de) |
WO (1) | WO2007144080A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009214307A1 (en) * | 2008-02-13 | 2009-08-20 | Bayer Intellectual Property Gmbh | Drug delivery system with stabilising effect |
JP2011511823A (ja) * | 2008-02-13 | 2011-04-14 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | エストラジオール含有薬物の送達システム |
CN101966151B (zh) * | 2010-09-06 | 2011-11-09 | 海南美大制药有限公司 | 马来酸曲米帕明脂质体固体制剂 |
US9687445B2 (en) | 2012-04-12 | 2017-06-27 | Lts Lohmann Therapie-Systeme Ag | Oral film containing opiate enteric-release beads |
WO2016138357A1 (en) | 2015-02-27 | 2016-09-01 | Kindred Biosciences, Inc. | Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats |
CN106729652A (zh) * | 2016-11-30 | 2017-05-31 | 郑州仁宏医药科技有限公司 | 一种治疗抑郁症的西药组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043728A1 (de) * | 1999-12-14 | 2001-06-21 | Lts Lohmann Therapie-Systeme Ag | Flache arzneizubereitung zur transmucosalen verabreichung von oxycodon oder einem vergleichbaren wirkstoff in der mundhöhle, für die anwendung in der schmerztherapie und suchttherapie |
WO2003070227A1 (de) * | 2002-02-21 | 2003-08-28 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung |
WO2004105767A1 (en) * | 2003-06-02 | 2004-12-09 | Sigma Pharma Ltda. | Pharmaceutical composition based on agonist of benzodiazepine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10018834A1 (de) * | 2000-04-15 | 2001-10-25 | Lohmann Therapie Syst Lts | Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung |
DE10328942A1 (de) * | 2003-06-27 | 2005-01-27 | Lts Lohmann Therapie-Systeme Ag | Transmukosale Darreichungsformen mit verminderter Schleimhautirritation |
DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
-
2006
- 2006-06-16 DE DE102006027792A patent/DE102006027792A1/de not_active Withdrawn
-
2007
- 2007-06-04 CA CA002652476A patent/CA2652476A1/en not_active Abandoned
- 2007-06-04 CN CNA2007800206943A patent/CN101460145A/zh active Pending
- 2007-06-04 JP JP2009514661A patent/JP2009539892A/ja not_active Withdrawn
- 2007-06-04 EP EP07725804A patent/EP2029097A2/de not_active Withdrawn
- 2007-06-04 WO PCT/EP2007/004936 patent/WO2007144080A2/de active Application Filing
- 2007-06-04 US US12/308,194 patent/US20090203670A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001043728A1 (de) * | 1999-12-14 | 2001-06-21 | Lts Lohmann Therapie-Systeme Ag | Flache arzneizubereitung zur transmucosalen verabreichung von oxycodon oder einem vergleichbaren wirkstoff in der mundhöhle, für die anwendung in der schmerztherapie und suchttherapie |
WO2003070227A1 (de) * | 2002-02-21 | 2003-08-28 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung |
WO2004105767A1 (en) * | 2003-06-02 | 2004-12-09 | Sigma Pharma Ltda. | Pharmaceutical composition based on agonist of benzodiazepine |
Non-Patent Citations (1)
Title |
---|
BAILER U ET AL: "MIRTAZAPIN BEI STATIONAER BEHANDELTEN DEPRESSIVEN PATIENTEN", WIENER KLINISCHE WOCHENSCHRIFT, NEW YORK, NY, US, vol. 18, no. 18, October 1998 (1998-10-01), pages 621 - 624, XP000922646, ISSN: 0043-5325 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007144080A2 (de) | 2007-12-21 |
DE102006027792A1 (de) | 2007-12-20 |
CA2652476A1 (en) | 2007-12-21 |
US20090203670A1 (en) | 2009-08-13 |
JP2009539892A (ja) | 2009-11-19 |
CN101460145A (zh) | 2009-06-17 |
EP2029097A2 (de) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008028193A3 (en) | Colon-targeted oral formulations of cytidine analogs | |
WO2005097076A3 (en) | Low dose pharmaceutical products | |
TNSN08079A1 (en) | Pharmaceutical compositions for the treatment of inner ear disorders | |
HK1111609A1 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
WO2008128740A8 (en) | Titration of tapentadol | |
WO2013158814A8 (en) | Immediate release, abuse deterrent pharmaceutical compositions | |
MX2012007410A (es) | Compuestos antivirales novedosos. | |
DE60121301D1 (de) | Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen | |
WO2007144080A3 (de) | Antidepressiva-kombinations-wafer | |
WO2007002597A3 (en) | Modified-release formulations of a bupropion salt | |
WO2006089082A3 (en) | Transmucosal administration of drug compositions for treating and preventing disorders in animals | |
SG166115A1 (en) | Pharmaceutical preparation containing meloxicam | |
WO2008021113A3 (en) | Transdermal methods and systems for treating alzheimer's disease | |
NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
NO20071354L (no) | anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme. | |
TW200602090A (en) | Antibiotic-based pharmaceutical formulation in microcapsular form | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
WO2008116890A3 (en) | Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders | |
BRPI0513598A (pt) | formas de dosagem em comprimidos revestidos de liberação entérica | |
WO2010090494A3 (ko) | 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도 | |
WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
WO2006008173A3 (en) | Pharmaceutical formulations for inhalation | |
WO2008148573A3 (de) | Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen | |
WO2006115770A3 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780020694.3 Country of ref document: CN |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07725804 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2652476 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007725804 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12308194 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009514661 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
ENP | Entry into the national phase |
Ref document number: PI0711248 Country of ref document: BR Kind code of ref document: A2 Effective date: 20081128 |